New York, September 24, 2013 -- Moody's Investors Service assigned a Baa3 rating to Edwards Lifesciences Corporation's ("Edwards") new senior unsecured note offering. Proceeds will be used to repay outstandings under its revolving credit facility as well as for general corporate purposes. There is no change to Edwards' senior unsecured shelf rating. The rating outlook is stable.

Vollständigen Artikel bei Moodys lesen